Azelis Reports 15% Growth in Adjusted EBITA for Q1 2023 : vi

Regulatory News: Azelis(Brussels:AZE): Q1 2023 Highlights Revenue of EUR 1.1bn in Q1 2023, representing year-on-year growth of 12.0%. Organic revenue was broadly stable, following a record

Related Keywords

Israel , United States , New Zealand , Brazil , Australia , China , Belgium , America , Belgian , Asia Pacific , Hans Joachim , Life Sciences , Azelis Group , Belgian Financial Services , Revenue In Life Sciences , Group Revenues , Group Revenue , Group Gross Profit , Euronext , Regulatory News , Latin America , Vogler Ingredients , Working Capital Revenue , Net Working Capital , Cash Flow , Smoky Light , Chemiplas Agencies , Industrial Chemicals , Senior Unsecured Notes , Lidorr Elements , Annual Report , Euronext Brussels , Markets Authority , Investor Relations , Gefallene Big Techs , Azelis , Reports , Growth , Djusted , Mbita , 023 ,